Evidence map›Paper›PMID 41152666›Full record

ArticleWorld journal of urology2025

Impact of patient characteristics and comorbidities on the risk of postoperative acute kidney injury: a comparative analysis of on clamp vs. off-clamp techniques.

Alfonso Santangelo, Pietro Scilipoti, Giuseppe Rosiello, Mattia Longoni, Arianna Bettiga, Chiara Re, Giacomo Musso, Francesco Cei, Lucia Salerno, Federico Belladelli and 10 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alfonso SantangeloDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Pietro ScilipotiDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Giuseppe RosielloDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy. rosiello.giuseppe@hsr.it.
Mattia LongoniDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Arianna BettigaDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Chiara ReDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Giacomo MussoDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Francesco CeiDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Lucia SalernoDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Federico BelladelliDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Pierre I KarakiewiczCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada.
Alexandre MottrieDepartment of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium.
Alberto BrigantiDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Andrea SaloniaDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Roberto BertiniDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Rayan MatloobDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Francesco TrevisaniDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Francesco MontorsiDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Alessandro LarcherDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
Umberto CapitanioDepartment of Urology, Division of Experimental Oncology/Unit of Urology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe role of patient comorbidities in predicting acute kidney injury (AKI) following on-clamp versus off-clamp partial nephrectomy (PN) remains unclear. We investigated how patient characteristics affect the risk of postoperative AKI based on the on-clamp vs. off-clamp surgical technique.

methodsWithin a prospectively maintained database, patients treated with PN for renal cell carcinoma at a tertiary-referral center (2000–2024) were selected. Patients were categorized into two groups based on on-clamp versus off-clamp PN. AKI was defined using the K-DIGO criteria. A multivariable logistic regression model (LRM) assessed the risk of AKI by the presence of ischemia [covariates: age, gender, estimated blood loss, operative time, surgical approach (minimally invasive vs. open), tumor size, preoperative estimated glomerular filtration rate(eGFR)]. Additional separate LRMs evaluated the impact of comorbidities (overweight, age, smoking status, hypertension, gender, diabetes, hypercholesterolemia) on AKI risk according to on and off-clamp technique.

resultsOf 1,048 patients, 802 (77%) underwent on-clamp PN and 246 (23%) underwent off-clamp PN. Patients in the first group had larger median tumor sizes (3.10 cm vs. 2.50 cm, p < 0.001), lower estimated blood loss (200 ml vs. 240 ml, p < 0.001), but longer operative time (160 min vs. 140 min, p < 0.001). Comorbidity distribution was similar between groups, except for hypertension, which was less common in the on-clamp group (49% vs. 59%, p = 0.003). At LRM on-clamp PN was associated with a higher risk of AKI (OR: 2.00, p = 0.003). The effect of being overweight on AKI risk was stronger in the on-clamp group (OR: 1.87, p = 0.001) compared to the off-clamp group (OR: 1.01, p > 0.9). Similarly, age (OR: 1.03, p = 0.038 vs. 1.01, p = 0.7), smoking (OR: 1.58, p = 0.014 vs. 0.98, p > 0.9), hypertension (OR: 1.69, p = 0.010 vs. 1.49, p = 0.4), and male gender (OR: 1.62, p = 0.021 vs. 1.05, p > 0.9) were associated with AKI risk in patients receiving on-clamp PN.

conclusionsIn the on-clamp cohort there was association of BMI, age, active smoking, hypertension and gender with post-operative AKI. These findings underscore the importance of patient selection and preoperative planning, emphasizing the need to include individual patient characteristics when deciding on the surgical approach together with cancer features.

Indexed as

Acute Kidney InjuryCarcinoma, Renal CellKidney NeoplasmsNephrectomyPostoperative ComplicationsAgedComorbidityConstrictionFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAcute kidney injuryOff-clampOn-clampPartial nephrectomyPatient characteristics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.